Wiley, Journal of Medical Virology, 1(54), p. 7-11, 1998
DOI: 10.1002/(sici)1096-9071(199801)54:1<7::aid-jmv2>3.0.co;2-b
Wiley, Journal of Medical Virology, 1(54), p. 7-11
DOI: 10.1002/(sici)1096-9071(199801)54:1<7::aid-jmv2>3.3.co;2-9
Full text: Unavailable
In hepatitis C virus (HCV) infection, persistent viraemia can occur after successful biochemical response to interferon treatment. To assess whether this unusual profile might be due to trivial amounts of remaining virus or to the emergence of less pathogenic HCV strains, pre- and posttreatment sera from 27 patients who remained with HCV-RNA, despite sustained transaminase normalisation after interferon therapy, were investigated. All but one had infection by genotype 2 (P